These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9483877)

  • 1. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome].
    Suzuki J; Matsubuchi S; Yoshihara E; Kobayashi S; Okamura K; Okuda T; Okazaki M; Furuya N; Uchimura H; Tokunaga T; Shimazaki S
    Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Properties of extracellular products produced by group A streptococci isolated from patient with streptococcal toxic shock syndrome].
    Suzuki J; Yoshihara E; Kobayashi S
    Kansenshogaku Zasshi; 1997 Mar; 71(3):273-8. PubMed ID: 9128015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
    Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.
    Shiseki M; Miwa K; Nemoto Y; Kato H; Suzuki J; Sekiya K; Murai T; Kikuchi T; Yamashita N; Totsuka K; Ooe K; Shimizu Y; Uchiyama T
    Microb Pathog; 1999 Oct; 27(4):243-52. PubMed ID: 10502465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.
    Reichardt W; Müller-Alouf H; Alouf JE; Köhler W
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):313-22. PubMed ID: 1478466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Reichardt W; Alouf JE
    Adv Exp Med Biol; 1997; 418():241-3. PubMed ID: 9331642
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma globulin, Evan's blue, aprotinin A PLA2 inhibitor, tetracycline and antioxidants protect epithelial cells against damage induced by synergism among streptococcal hemolysins, oxidants and proteinases: relation to the prevention of post-streptococcal sequelae and septic shock.
    Ginsburg I; Sadovnic M
    FEMS Immunol Med Microbiol; 1998 Nov; 22(3):247-56. PubMed ID: 9848686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor.
    Gerlach D; Knöll H; Köhler W; Ozegowski JH; Hríbalova V
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):221-33. PubMed ID: 6359775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
    Eriksson BK; Andersson J; Holm SE; Norgren M
    J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections.
    Musser JM
    Pediatr Ann; 1992 Dec; 21(12):821-2, 825-8. PubMed ID: 1480436
    [No Abstract]   [Full Text] [Related]  

  • 11. An anti-perfringolysin O monoclonal antibody cross-reactive with streptolysin O protects against streptococcal toxic shock syndrome.
    Matsumura T; Nishiyama A; Aiko M; Ainai A; Ikebe T; Chiba J; Ato M; Takahashi Y
    BMC Res Notes; 2020 Sep; 13(1):419. PubMed ID: 32891180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS).
    Reichardt W; Müller-Alouf H; Köhler W
    Zentralbl Bakteriol; 1993 Jun; 279(2):283-93. PubMed ID: 8219499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virulence of Streptococcus canis from canine streptococcal toxic shock syndrome and necrotizing fasciitis.
    DeWinter LM; Low DE; Prescott JF
    Vet Microbiol; 1999 Oct; 70(1-2):95-110. PubMed ID: 10591501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of the Pathogenic Features of Streptococcus pyogenes Isolates from Invasive and Non-Invasive Diseases in Aichi, Japan.
    Matsumoto M; Yamada K; Suzuki M; Adachi H; Kobayashi S; Yamashita T; Minagawa H; Tatsuno I; Hasegawa T
    Jpn J Infect Dis; 2016 Jul; 69(4):338-41. PubMed ID: 26567838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.
    Hauser AR; Stevens DL; Kaplan EL; Schlievert PM
    J Clin Microbiol; 1991 Aug; 29(8):1562-7. PubMed ID: 1684795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.
    Mascini EM; Jansze M; Schouls LM; Verhoef J; Van Dijk H
    Int J Antimicrob Agents; 2001 Oct; 18(4):395-8. PubMed ID: 11691576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.
    Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E
    N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.
    Lee PK; Schlievert PM
    J Clin Microbiol; 1989 Aug; 27(8):1890-2. PubMed ID: 2504778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates.
    Newton D; Norrby-Teglund A; McGeer A; Low DE; Schlievert PM; Kotb M
    Adv Exp Med Biol; 1997; 418():525-9. PubMed ID: 9331707
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.
    Talkington DF; Schwartz B; Black CM; Todd JK; Elliott J; Breiman RF; Facklam RR
    Infect Immun; 1993 Aug; 61(8):3369-74. PubMed ID: 8335368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.